B型/C型肝炎治療の米国市場における戦略的分析

Strategic Analysis of the U.S. Hepatitis B and C Markets

発行	Frost & Sullivan
出版日	2006年01月	商品コード	40437
ページ情報	英文
価格	US$ 3,950 換算 ¥ 317,856 (税抜) Web Access (Regional License) US$ 4,450 換算 ¥ 358,091 (税抜) Hard Copy & Web Access (Regional License)

概要
原文目次
関連レポート

原文目次

Abstract

This Frost & Sullivan research service entitled Strategic Analysis of U.S. Hepatitis B and C Markets provides strategic recommendations and SWOT analysis, patient and pricing forecasts, market share analysis, and analysis of existing and new products. In this research, Frost & Sullivan's expert analysts thoroughly examine the Total Market along with the U.S. Hepatitis B and U.S. Hepatitis C Markets.

This analysis is available through our Pharmaceutical & Biotechnology Growth Partnership Services program. With this program, clients receive industry-leading market research such as this, along with technical and econometric data and many interactive features including Analyst Inquiry Time and Client Councils.

1. Executive Summary

1. Executive Summary
- 1. Executive Summary

2. Total Hepatitis Markets

1. Market Overview
- 1. Introduction
- 2. Market Segmentation
- 3. Research Methodology
2. SWOT Analysis and Revenue Forecast
- 1. SWOT Analysis
- 2. Revenue Forecasts
3. Industry Challenges and Strategies
- 1. Industry Challenges
- 2. Strategic Recommendations
4. Frost and Sullivan Awards
- 1. Entrepreneurial Company Award

3. U.S. Hepatitis B Market

1. Market Overview
- 1. Introduction
- 2. Market Engineering Measurements
2. Market Forecast and Trends
- 1. Patient Forecast
- 2. Pricing Forecast
- 3. Revenue Forecast
- 4. Market Trends
3. Competitive Analysis
- 1. Competitive Structure
- 2. Market Share Analysis

4. U.S. Hepatitis C Market

1. Market Overview
- 1. Introduction
- 2. Market Engineering Measurements
2. Market Forecast
- 1. Patient Forecast
- 2. Pricing Forecast
- 3. Revenue Forecast
- 4. Market Trends
3. Competitive Analysis
- 1. Competitive Structure
- 2. Market Share Analysis

5. Decision Support Databases

1. Disease Incidence
- 1. HIV Prevalence
- 2. AIDS Incidence
- 3. Hepatitis B Incidence
2. Healthcare Expenditure
- 1. Pharmaceutical R&D Expenditure
- 2. Percentage Pharmaceutical R&D Expenditure
- 3. Total Healthcare Expenditure